Back

The optimal plasma volume status in heart failure in relation to clinical outcome

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Patient management - From oral treatment to transplant Pathophysiology HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Pieter Martens

Hospital Oost-Limburg (ZOL), Genk (Belgium)

14 More presentations in this session

Presentation thumbnail
Structured follow-up program of patients with heart failure: impact on quality of life and prognosis.
Doctor J. AGOSTINHO (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Impact of physicians' adherence to guideline-recommended therapy on heart failure re-hospitalizations: data from the Optimize Heart Failure Care Program
Doctor A. Grebennikova (Volgograd, RU)
Abstract Slides Video
Presentation thumbnail
Perceptions of heart failure treatment decision-making and side effects of heart failure treatment by patients and cardiologists: a multinational survey in the real-world cardiology setting
Doctor S. Bruce Wirta (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
CANCELLED - The effect of home-based cardiac rehabilitation following coronary artery bypass graft surgery in a low income country: A controlled trial
Mr J. Uddin (Dhaka, BD)
Abstract
Presentation thumbnail
Empagliflozin improves renal outcomes in patients with or without heart failure at baseline - insights from the EMPA-REG OUTCOME trial
Professor J. Butler (Dallas, US)
Abstract Slides Video

Access the full session

Session thumbnail
Patient management - From oral treatment to transplant

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Chronic kidney disease and heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources